MAPK8 and cancer: Beyond CRC, PARP14 contributes to tumorigenesis in B-cell lymphoma by inhibiting JNK1 (MAPK8) signaling, thereby preventing apoptosis, and in acute myeloid leukemia by enhancing glycolysis to support cancer cell proliferation (Barbarulo et al., 2013).